It is critical to consider existing medications and medical background, as these drugs should not be combined with certain other treatments, including GLP-1 receptor agonists
CVOTs primarily proved cardiovascular safety and tolerability of different GLP-1 receptor agonists, but also showed cardiovascular benefit of specific drugs
It pairs well with hydrating ingredients, such as hyaluronic acid
Note: Direct human studies measuring GLP-1 levels after psyllium intake are limited, but existing data on fiber-driven GLP-1 activity suggest a clear mechanistic link
Voysey M, Clemens SAC, Madhi SA, et al
Its currently in phase III clinical trials, which is the final stage before approval